Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder
Clinical trial NCT00635219 · COMPLETED
Trial details
- NCT number
- NCT00635219
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2009-04-01
- Enrollment
- 766
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.